BioSpace News Archive

Pharm Country

Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced six poster abstracts across its neurology portfolio will be presented at the American Academy of Neurology (AAN) Annual Meeting on April 22-27, 2023.

April 11, 2023

·

14 min read

Drug Development

Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses

Veru Inc. today announced results from a preclinical in vitro study evaluating the effects of sabizabulin against prototypical poxvirus, vaccinia virus, which demonstrated that sabizabulin prevented both the release of poxvirus from infected cells and the spread of poxvirus to healthy cells.

April 11, 2023

·

13 min read

BioCapital

Prelude Therapeutics to Present at American Association for Cancer Research 2023 ConferenceEight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline

Prelude Therapeutics Incorporated today announced details relating to eight abstracts being presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19 in Orlando, Florida.

April 11, 2023

·

6 min read

BioMidwest

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

Surmodics, Inc. today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference, which is being held from April 17-20, 2023.

April 11, 2023

·

1 min read

Business

Legend Biotech Announces Appointment of Chief Medical Officer

Legend Biotech Corporation today announced the appointment of Mythili Koneru, M.D., Ph.D. as the Company’s Chief Medical Officer.

April 11, 2023

·

2 min read

Business

RenovoRx Appoints Leesa Gentry as Senior Vice President of Clinical Operations

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, announced today that Leesa Gentry has joined the Company as Senior Vice President of Clinical Operations.

April 11, 2023

·

8 min read

Business

Xenetic Biosciences, Inc. Announces Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

Xenetic Biosciences, Inc. today announced it has entered into a Research Funding and Option Agreement (the “Agreement”) with The Scripps Research Institute (“TSRI”) to advance the development of the Company’s systemic DNase program as well as its DNase-armored CAR T program.

April 11, 2023

·

7 min read

Business

LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes

LyGenesis, Inc. and Imagine Pharma , a biotechnology company focused on the development of its novel polypeptide (IMG-1) across three distinct platforms.

April 11, 2023

·

4 min read

Lunit Demonstrates Progress in the Development of Novel Diagnostics at the 2023 AACR Annual Meeting

Lunit will deliver five poster presentations featuring its AI-biomarker platform, Lunit SCOPE IO, at the annual meeting to be held in Orlando, Florida, on April 14-19.

April 11, 2023

·

6 min read

Business

HDAX Therapeutics Announces Appointment of Drs. Roman Fleck and Neal I. Muni to Board of Directors

HDAX Therapeutics, Inc. announced the appointment of Roman Fleck, Ph.D. as Executive Chairman of the Board and Neal I. Muni, M.D., MSPH, as an independent Board member.

April 11, 2023

·

3 min read